17
Grape King Bio Ltd
1707.TW · TAI
$90.70 +0.22% (+$0.20)
1M +0.22%
Market Cap $13.5B
P/E Ratio 11.74x
Div. Yield 4.18%
ROE 11.28%
Bulios Fair Price
$96.18
6.0% upside
Current Price
$90.7
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 1707.TW is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
100 /100
Cheap P/E 11.74x
P/B 1.32x
EV/EBITDA 3.85x
Growth
10 /100
Declining EPS growth 17.52%
Book val. growth 2.62%
Rev. growth 0.45%
Profitability
85 /100
Strong Gross margin 72.88%
FCF margin 14.77%
Net margin 11.34%
Quality
64 /100
Average ROIC 13.87%
Asset turnover 0.67x
ROE 11.28%
Debt
97 /100
Low Debt/Equity 0.02x
Net debt/EBITDA -1.27x
Current ratio 1.59x
Stability
76 /100
Stable Beta 0.23x
Profitable years 6
Rev. volatility 6.92%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about 1707.TW
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Sheng-Lin Tseng
Employees
501
Headquarters
Taoyuan City
Upcoming events
11 NOV
Earnings
Upcoming earnings report